BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 11, 1998
View Archived Issues
Genzyme Tissue Repair: Q3 1998 highlights
Read More
Gliatech: Q3 1998 highlights
Read More
NeoRx announces license agreement with Angiotech
Read More
AltaRex seeks permission to study immunological activity of OvaRex in phase II trial
Read More
Nonpeptide CRF1 antagonist developed at Parke-Davis modulates brain NE levels
Read More
ATTRACT study establishes efficacy, safety of infliximab in RA patients
Read More
European phase III trial of Macritonin produces positive analysis of one-year BMD data
Read More
LY-300164 protects against kainate-induced neurotoxicity in vitro in a stereoselective manner
Read More
Chiron initiates phase II testing of rFGF-2
Read More
Positive phase II results reported for potential asthma treatment
Read More
Synthelabo presents in vitro, ex vivo and in vivo data on new MAO-B inhibitor
Read More
Unexpected adverse events encountered with bosentan in REACH-1 trial
Read More
Chugai describes inhibitors of iNOS, nNOS
Read More
Selective inhibitors of vascular wall, microsomal ACAT developed at Kowa
Read More
Nicotinic acetylcholine receptor ligands for nicotine addiction and CNS disorders
Read More
Pyridyl compounds claimed by Astra for the Rx of asthma and rhinitis
Read More
Proton pump inhibitors in the pipeline at Yuhan
Read More
PD-161989: novel AMPA/GLYN receptor antagonist related to PNQX
Read More
RenaGel available this month in the U.S.
Read More
Synthelabo presents new 5-HT1A inverse agonist with antagonist and anxiolytic-like activity in vivo
Read More
New anticancer drug candidate revealed by Sugen; product enters phase I testing in U.K.
Read More
Neuroprotective effects of NCC-161, a new neuronal calcium antagonist
Read More
European filing announced for Enbrel
Read More
Photoangioplasty with Antrin reduces atherosclerotic plaque in rabbit models
Read More
Inhibition of cytokine production contributes to the antiinflammatory activity of orazipone
Read More
Cytel's VLA4 antagonist shows potential for treating allergic lung inflammation
Read More
First clinical trial of oral neurophilin compound in patients with diabetic neuropathy
Read More
Improved dosage form of selegiline now on the U.K. market
Read More
Radiopharmaceutical for chronic knee synovitis in development at British university
Read More
